Weight-loss drugs such as Ozempic were in the headlines a lot in 2025 and patent protections for these drugs expire in some countries in 2026
I think I will wait until the Johnson and Johnson vaccine
This information is provided for educational and wellness purposes only and does not diagnose, treat, or recommend any specific medication, peptide, or therapy, some of which may be prescription-only, investigational, or intended for research use only
Currently about 2,100 Suffolk County employees or beneficiaries not on Medicare have active prescriptions for GLP-1 medications, according to county spokesman Mike Martino
Ozempic is semaglutide, a GLP-1 receptor agonist
Its active ingredient, semaglutide , is a GLP-1 receptor agonist that significantly aids in long-term weight management by slowing gastric emptying and reducing appetite